A Study to Evaluate the Impact of Management Strategies on Gastrointestinal-Related Adverse Events in Participants With Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations Receiving TAK-788
Clinical trial NCT04576208 · WITHDRAWN
Trial details
- NCT number
- NCT04576208
- Sponsor
- Takeda
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-30
- Primary completion
- 2022-07-31
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.